FATHER SATURNINO URIOS UNIVERSITY

San Francisco St. Butuan City 8600, Region XIII Caraga, Philippines
Nursing Program

Name of students: Nikki Caryl A. Zafra

Date: December 18, 2020
Section: N32
DRUG STUDY
Name Dose Classification Mechanism of Action Indication Contraindication Adverse Effect Nursing Responsibility
of Drug
Aricept 5mg Anti-Alzheimer/ Reversibly This Hypersensitivity, Diarrhea, muscle • Assess the cognitive function of
OD PO Cholinergic Inhibit acetylcholinee indicates patient with cramps, fatigue, the patient also heart rate.
sterase in the CNS treatment cardiac disease, n&V, insomnia, • Hold the medication if the
(cerebral cortex), for mild, ulcers, taking dizziness, psychiatric medication is less than 60 bpm.
resulting to increased moderate NSAID, hx of disturbances, • Check the patient after giving
acetylcholine levels and severe seizure, and headache the medication if there is the
because of slow Alzheimer’s asthma improvement of cognitive
degradation. It does disease. function.
not alter underlying • Instruct the patient to avoid
dementia but hazardous activities such as
temporarily improves driving, and encourage to take
cognitive function in safety precautions to prevent
patients w/ from falling if the patient
Alzheimer’s disease. experiences adverse rxn such as
dizziness.
• If the pt. has peptic ulcer,
explain to the patient that the
drug may aggravate this
condition by increasing gastric
acid and secretion.
 Name of Dose Classification Mechanism of Indication Contraindication Adverse Effect Nursing Responsibility
Drug Action
Colchicine 500 mcg Antigout Colchicine Colchicine Blood dyscrasias. abdominal cramping, • Monitor patient who has
1-tab drugs reduces capsules are Severe renal (including abdominal pain, used drug for prolonged
OD; PO neutrophil- indicated for hemodialysis diarrhea, lactose period for neuromuscular
mediated prophylaxis of patients), and hepatic intolerance, nausea, toxicity and rhabdomyolysis.
inflammatory gout flares in impairment (except in vomiting, sensory • If the patient experience
response by adults. familial Mediterranean motor neuropathy, nausea and vomiting or
disrupting fever). Concomitant alopecia, diarrhea occurs then
cytoskeletal use with P- maculopapular rash, discontinue the drugs.
functions glycoprotein (P-gp) purpura, rash, muscle • Explain to patient that drug
thereby blocking inhibitors or strong weakness, muscle can be taken without regard
the β-tubulin CYP3A4 inhibitors in pain to food but to avoid grape
polymerisation patients with renal or fruit juice.
into hepatic impairment. • Advise the patient to report
microtubules, all adverse reactions
and preventing including muscle pain or
the activation, weakness, tingling or
degranulation, numbness in fingers or toes
and migration of unusual bleeding, cyanosis
neutrophils into then discontinue the
the inflamed medications.
area.